Literature DB >> 20484586

Oxidative stress and the regulation of complement activation in human glaucoma.

Gülgün Tezel1, Xiangjun Yang, Cheng Luo, Angela D Kain, David W Powell, Markus H Kuehn, Henry J Kaplan.   

Abstract

PURPOSE: As part of ongoing studies on proteomic alterations during glaucomatous neurodegeneration, this study focused on the complement system.
METHODS: Human retinal protein samples obtained from donor eyes with (n = 10) or without (n = 10) glaucoma were analyzed by a quantitative proteomic approach using mass spectrometry. Cellular localization of protein expression for different complement components and regulators were also determined by immunohistochemical analysis of an additional group of human donor eyes with glaucoma (n = 34) compared with age-matched control eyes without glaucoma (n = 20). In addition, to determine the regulation of complement factor H (CFH) by oxidative stress, in vitro experiments were performed using rat retinal cell cultures incubated in the presence and absence of an oxidant treatment.
RESULTS: Proteomic analysis detected the expression and differential regulation of several complement components in glaucomatous samples, which included proteins involved in the classical and the lectin pathways of complement activation. In addition, several complement regulatory proteins were detected in the human retinal proteome, and glaucomatous samples exhibited a trend toward downregulation of CFH expression. In vitro experiments revealed that oxidative stress, which was also prominently detectable in the glaucomatous human retinas, downregulated CFH expression in retinal cells.
CONCLUSIONS: These findings expand the current knowledge of complement activation by presenting new evidence in human glaucoma and support that despite important roles in tissue cleaning and healing, a potential deficiency in intrinsic regulation of complement activation, as is evident in the presence of oxidative stress, may lead to uncontrolled complement attack with neurodestructive consequences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484586      PMCID: PMC3066595          DOI: 10.1167/iovs.10-5289

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  80 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

2.  Comparative gene array analysis of TNF-alpha-induced MAPK and NF-kappaB signaling pathways between retinal ganglion cells and glial cells.

Authors:  Gülgün Tezel; Xiangjun Yang
Journal:  Exp Eye Res       Date:  2005-08       Impact factor: 3.467

3.  Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma.

Authors:  Michael R Steele; Denise M Inman; David J Calkins; Philip J Horner; Monica L Vetter
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

4.  Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes.

Authors:  Kalliopi Stasi; Dalia Nagel; Xiaoyan Yang; Rong-Fang Wang; Lizhen Ren; Steven M Podos; Thom Mittag; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

5.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

Review 7.  Membrane complement regulatory proteins.

Authors:  David D Kim; Wen-Chao Song
Journal:  Clin Immunol       Date:  2005-12-09       Impact factor: 3.969

8.  Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma.

Authors:  Gülgün Tezel; Xiangjun Yang; Jian Cai
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-09       Impact factor: 4.799

9.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

Authors:  Gregory S Hageman; Don H Anderson; Lincoln V Johnson; Lisa S Hancox; Andrew J Taiber; Lisa I Hardisty; Jill L Hageman; Heather A Stockman; James D Borchardt; Karen M Gehrs; Richard J H Smith; Giuliana Silvestri; Stephen R Russell; Caroline C W Klaver; Irene Barbazetto; Stanley Chang; Lawrence A Yannuzzi; Gaetano R Barile; John C Merriam; R Theodore Smith; Adam K Olsh; Julie Bergeron; Jana Zernant; Joanna E Merriam; Bert Gold; Michael Dean; Rando Allikmets
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

10.  A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.

Authors:  Young-Sun Kang; Yoonkyung Do; Hae-Kyung Lee; Sung Ho Park; Cheolho Cheong; Rebecca M Lynch; Jutta M Loeffler; Ralph M Steinman; Chae Gyu Park
Journal:  Cell       Date:  2006-04-07       Impact factor: 41.582

View more
  90 in total

1.  Proteomics analyses of human optic nerve head astrocytes following biomechanical strain.

Authors:  Ronan S Rogers; Moyez Dharsee; Suzanne Ackloo; Jeremy M Sivak; John G Flanagan
Journal:  Mol Cell Proteomics       Date:  2011-11-29       Impact factor: 5.911

2.  Biomarkers for glaucoma: from the lab to the clinic.

Authors:  N Von Thun Und Hohenstein-Blaul; S Kunst; N Pfeiffer; F H Grus
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

3.  Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.

Authors:  Alejandra Bosco; Sarah R Anderson; Kevin T Breen; Cesar O Romero; Michael R Steele; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Stephen Tomlinson; Monica L Vetter
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

4.  Retinal gene expression changes related to IOP exposure and axonal loss in DBA/2J mice.

Authors:  Lambros Panagis; Xiujun Zhao; Yongchao Ge; Lizhen Ren; Thomas W Mittag; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-03       Impact factor: 4.799

5.  Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration.

Authors:  Haoyu Mao; Soo Jung Seo; Manas R Biswal; Hong Li; Mandy Conners; Arathi Nandyala; Kyle Jones; Yun-Zheng Le; Alfred S Lewin
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-01       Impact factor: 4.799

Review 6.  Neuroinflammation in glaucoma: A new opportunity.

Authors:  Pete A Williams; Nick Marsh-Armstrong; Gareth R Howell
Journal:  Exp Eye Res       Date:  2017-02-24       Impact factor: 3.467

7.  Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Authors:  Shravan K Chintala; Nahrain Putris; Mason Geno
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

8.  Alterations in molecular pathways in the retina of early experimental glaucoma eyes.

Authors:  Li Cao; Lin Wang; Grant Cull; An Zhou
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-03-20

Review 9.  [Basic biochemical processes in glaucoma progression].

Authors:  N von Thun und Hohenstein-Blaul; S Kunst; N Pfeiffer; F H Grus
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

Review 10.  Oxidative stress and potential applications of free radical scavengers in glaucoma.

Authors:  Mutay Aslan; Serdar Dogan; Ertan Kucuksayan
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.